close

Fundraisings and IPOs

1 2 3 4 5 68
Number of results: 1351
Date Company Amount Funding type Investors Therapeutic area Type of Information
2017-08-08 Radius Health (USA - MA) $300 million private placement Bone diseases - Cancer - Oncology - Endocronological diseases Private placement
2017-08-07 Cuorips (Japan) investment Daiichi Sankyo (Japan) Fundraising
2017-08-04 Lonza (Switzerland) € 700 million and $ 200 million private placement Technology - Services Company acquisition
2017-08-01 Homology Medicines (USA - MA) $83.5 million series B financing round 5AM Ventures (USA - CA) Alexandria Venture Investments (USA - MA) ARCH Venture Partners (USA - IL) Deerfield Management (USA - NY) Fidelity Management and Research Company (US - MA) HBM Healthcare Investments (Switzerland) Maverick Ventures USA - CA) Novartis (Switzerland) Rock Springs Capital (USA - MD) Vida Ventures (Canada) Vivo Capital (USA - CA) Rare diseases - Genetic diseases Series B financing round
2017-07-31 Neovacs (France) €6.0 million private placement undisclosed U.S. institutional investors Autoimmune diseases Private placement
2017-07-28 Iteos Therapeutics (Belgium) € 7.5 million grant Walloon Region (Belgium) Cancer - Oncology Grant
2017-07-26 Quantum Genomics (France) € 8.2 Million capital increase Cardiovascular diseases Capital increase
2017-07-25 Antabio (France) up to $8.9 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Debiopharm (Switzerland) up to $ 4 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Achaogen (USA - CA) up to $ 11.5 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Bugworks Research Inidia (India) up to $ 6.2 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Eligochem (UK) up to $ 4.8 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Iterum Therapeutics (Ireland) up to $ 1.5 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 VenatoRx Pharmaceuticals (USA - PA) up to $ 9.4 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-19 Ose Immunotherapeutics (France) €9.2 million grant Bpifrance (France) Cancer - Oncology Grant
2017-07-19 Akcea Therapeutics (USA - MA) $193.8 million IPO - private placement Cardiovascular diseases - Metabolic diseases - Rare diseases IPO
2017-07-18 Eurofins Scientific (Luxembourg) € 65 million fundraising Technology - Services Fundraising
2017-07-18 Neurovive Pharmaceutical (Sweden) SEK 9 million (€ 0.94 million) private placement Esousa Holdings (USA - NY) Rare diseases - Genetic diseases - Liver diseases - Hepatic diseases Private placement
2017-07-17 Paion (Germany) € 8 million private placement two undisclosed U.S. institutional investors CNS diseases Private placement
2017-07-07 Biophytis (France) € 18,7 million capital increase - private placement Bracknor Investment Group (Dubai) Ageing diseases - Muscle disorders - Ophtalmological diseases Capital increase